Tenderwize
Retour à la recherche

CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD

Department of Contracts·Floriana, Malta·EUR 5.6M·Expired · Jul 15, 2026·Open·Supplies
High valueStructured notice only
Titre original de l'avis

Malta – Toxins – CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD

60/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesExpired
Pourquoi ce score ?

Opportunité

60 / 100

Complexité

45 / 100

Facteurs de risque

Award criteria and selection criteria are not disclosed, making bid preparation speculative.

Framework contract may not guarantee any minimum purchase volume.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • EUR 5.6M estimated value
  • Supplies contract
  • 1 lot
  • Supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for Inflammatory Bowel Disease (IBD)
  • Framework contract; no quantities or minimum spend specified
Afficher le résumé complet

This is an open procedure framework contract for the supply of selective Janus Kinase 1 inhibitor tablets/prolonged release tablets/capsules for inflammatory bowel disease (IBD). The contract is for a single lot with an estimated total value of €5,608,254.60. The buyer is the Department of Contracts in Malta. The deadline for submission is 15 July 2026 at 07:30 (Malta time). Electronic submission is required in English. The notice does not disclose award or selection criteria; only an ESPD (European Single Procurement Document) is referenced. No procurement documents were analyzed beyond the notice.

Risques

Award criteria and selection criteria are not disclosed, making bid preparation speculative.

Framework contract may not guarantee any minimum purchase volume.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must supply pharmaceutical products classified under CPV 33693100

Administrative

  • Electronic submission via eTenders Malta portal
  • Tender must be submitted in English

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Floriana, MLT

Profil acheteur

Ouvrir le profil

Identifiant

MT25645419

Activité

General public services

Lots (1)

LOT-0001

CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD

Supply of selective JAK1 inhibitor tablets/prolonged release tablets/capsules for IBD.

SuppliesEU fundedElectronic submission

EUR 5.6M

Valeur estimée

Localisation

MT001, Malta

Catégorie

Toxins

Date limite

Expired Jul 15, 2026

Détails de la procédure

Date de publication
10 Jun 2026
Langues
English

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
400302-2026

Documents (2)